Stay updated on APL-2 vs Sham in GA: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the APL-2 vs Sham in GA: Efficacy & Safety Clinical Trial page.

Latest updates to the APL-2 vs Sham in GA: Efficacy & Safety Clinical Trial page
- Check2 days agoChange DetectedThis page now shows a 403 Forbidden error instead of the study details, indicating the study record at this URL is inaccessible. The change prevents viewing core study information on this page.SummaryDifference17%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new publication citation has been added under Publications From PubMed for Syfovore approval for geographic atrophy (JAMA Ophthalmol. 2024). This provides updated literature context related to GA therapies.SummaryDifference0.0%

- Check23 days agoChange DetectedThe page’s revision metadata was updated from v3.6.5 to v3.6.6, indicating a new deployment of the page backend. This likely implements fixes or minor enhancements without altering the displayed study details.SummaryDifference0.0%

- Check44 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5 on the page, signaling a small update to the page’s content or metadata. No substantive study details appear to be altered.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision tag on the page was updated to v3.6.4, replacing the previous v3.6.3.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous v3.6.2, indicating an updated version of the study record.SummaryDifference0.0%

Stay in the know with updates to APL-2 vs Sham in GA: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-2 vs Sham in GA: Efficacy & Safety Clinical Trial page.